Objective: To describe a method for imputing missing follow-up blood pressure data in a clinical hypertension trial using blood pressures abstracted from medical charts. Methods: We tested a two-step method. In the first, a longitudinal mixed-effects model was estimated on blood pressures abstracted from medical charts. In the second, the patient-specific fitted values from this model at follow-up were used to impute blood pressures missing at follow-up in the trial. Simulations that imposed alternative missing data mechanisms on observed trial data were used to compare this approach to imputation approaches that do not incorporate data from charts. Results: For data that are missing at random, incorporating the fitted values from chart-based longitudinal models leads to estimates of the trial-based blood pressures that are unbiased and have lower mean squared deviation than do blood pressures imputed without the chart-based data. For data that are missing not at random, incorporating fitted values ameliorates but does not eliminate the inherent missing data bias. Conclusions: Incorporating chart data into an imputation algorithm via the use of longitudinal mixed-effects model is an efficient way to impute longitudinal data that are missing from a randomized trial.
Introduction
When a substantial percent of patients in a randomized trial fail to show up for their follow-up visit, the resulting missing outcome data can seriously confound the interpretation of the results of the trial [1] [2] [3] . Statistical techniques for handling missing data, such as single or multiple imputation (MI), can yield unbiased estimates of treatment effectiveness in the presence of missing data [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , provided that the missing data conform to a missing at random (MAR) mechanism. The MAR assumption holds that the probability that some outcome data is missing can depend on other observed variables, but not on the value of the outcome itself, conditional on the observed variables. That is, after controlling for other observed variables, the value of the outcome variable is not a predictor of missingness. MAR is a generally untestable assumption [12] , and whether it holds or not depends in part on the other observed variables available to the researcher. The more pertinent information a researcher has about the potentially missing outcome value, the more likely the MAR assumption is to hold.
Just such pertinent information may be available in patient medical charts, and utilizing this information may improve our ability to validly impute missing trial data. For example, a patient who fails to report for a follow-up blood pressure reading in a hypertension trial may nevertheless continue to keep appointments with his or her clinician who records the patient's blood pressure and other signs and symptoms in the medical chart in the course of routine medical care. It seems reasonable that these chart-based blood pressure readings should be useful for imputing the missing trial-based blood pressure readings, but incorporating the chart-based blood pressures into an imputation algorithm is complicated by two factors. First, the trial protocol specifies that the blood pressures be taken at specific times during the trial, and while the patient may have clinic visits before and after these times, she or he may not have a visit during the specific window of time when the trial blood pressure was scheduled to take place. Second, the blood pressure recorded in the medical chart may be systematically different than the blood pressure that would have been recorded by trial personnel. Trial protocols, personnel, and equipment for recording blood pressure are standardized, whereas clinic procedures and equipment can vary from one provider to the next. In addition, so-called white coat hypertension [13] may cause blood pressure readings in clinicians' offices to be systematically higher than those taken by trial personnel because patients' blood pressures respond to the anxiety associated with seeing a clinician.
The goal of this article is to describe a novel method for overcoming these two challenges to using chart-based information to impute data missing from a clinical trial, and to assess via simulation the utility of this method compared to standard methods of imputing missing trial data. We apply this method to the imputa-tion of missing blood pressure data from a hypertension trial. The method involves first specifying a mixed effects longitudinal model of blood pressure measurements taken from medical charts for each patient. From this model we recover the fitted value (both the fixed and random components) of patients' predicted blood pressures for the days the patients were scheduled for follow-up blood pressure measurements in the trial. We then use these data in either a single-or multiple-imputation framework to impute missing trial blood pressure measurements.
The article is organized into two parts. In the first part we describe the method and apply it to data from the trial. In the second part we conduct simulations to assess the utility of this new method compared to other commonly used imputation methods.
Data and Methods

Data
The data come from a randomized trial of nurse-led disease management for patients with uncontrolled hypertension in east and central Harlem in New York City. In this trial, 416 patients were randomized to receive usual care, a home blood pressure monitor, or a home blood pressure monitor plus follow-up counseling by a trained nurse. The outcomes were blood pressure at 9 months and 18 months, which were taken in person by trained study personnel with standardized equipment and procedures. These systolic and diastolic readings are referred to as trial-based blood pressures. Patients also consented to have their blood pressure and other medical information abstracted from their medical charts from 1 year before and 18 months after enrollment in the trial. These readings are referred to as chart-based blood pressures.
Methods: Combining chart-and trial-based blood pressures Incorporating chart-based blood pressures into an imputation algorithm requires several steps. In the first step we estimated a mixed effect linear model of chart-based blood pressure as a function of time as shown in equation (1)
Where Y c it is systolic blood pressure for patient i recorded from a medical chart at time t, which is days since enrollment in the trial; negative values represent pre-enrollment times. Time and its square appear as fixed effects in equation (1) to capture the overall trend in chart-based blood pressures over time.
Patient-specific random intercepts u 0i and random slopes u 1i capture the idiosyncratic mean and trajectory of blood pressure for each patient. More complex models that involved higher powers of time and random slopes for the t 2 term were also investigated, but the specification of equation (1) was chosen based on the Bayesian Information Criterion. We assumed an unstructured covariance matrix for the random effects to allow for a correlation between the random slopes and intercepts, and estimated the parameters using restricted maximum likelihood.
In the second step, we calculated the fitted value of equation (1) at t ϭ 274 and t ϭ 548, which correspond to 9 months and 18 months after trial entry, when patients in the trial were scheduled for a follow-up blood pressure measurement. These fitted values included estimates for the fixed components as well as predictions of the random components u 0i and u 1i . These fitted values are shrinkage estimators of what the systolic blood pressure would have been for a specific patient if that patient had an outpatient visit on the day she or he was scheduled for a follow-up blood pressure reading from study personnel. Shrinkage estimators are useful in this context because the estimates for patients with few chart-based blood pressure measurements with which to estimate an individual specific trend are "shrunk" toward the population mean estimated trend [14] .
In the third step, we tested if these fitted values are useful for predicting trial-based blood pressures at 9-and 18-month follow-up. We estimated a base model (equation 2a) that is a linear regression of trial-based blood pressure at follow-up month m (m ϭ 9,18) as a function of baseline characteristics X i , baseline trial-based systolic blood pressure Y s i0 , and a dummy variable I 18 (m) that is equal to one if month ϭ 18 and zero otherwise. Note that equation (2a) has no data in common with equation (1) . The former uses chart-based blood pressure as the dependent variable and contains no covariates other than continuous measures of time. The latter uses trial-based blood pressure, includes patient baseline characteristics, and represents time by a dummy variable.
We then estimated a comparison model (equation 2b) that included the fitted values Ŷ c im from equation (1) as an additional explanatory variable, and recorded the additional variance explained by this model in terms of adjusted R 2 . We used robust standard errors clustered on the patient to account for the maximum of two observations per patient.
Results: Combining chart-and trial-based blood pressures Table 1 shows that 416 patients enrolled in the trial at baseline and 152 had missing blood pressure readings at either 9 or 18 months after enrollment. Women and Hispanics were less likely to be missing at follow-up, and systolic blood pressure at baseline was somewhat higher among patients who would eventually miss a follow-up reading. These 416 patients had 3345 blood pressure readings recorded in medical charts during outpatient visits during the 2 years surrounding the trial, with a large number occurring before and after the trial. Slightly lower blood pressure readings were recorded at routine outpatient visits than during visits with trial personnel. Table 2 shows a comparison of longitudinal models for trialbased blood pressure, which correspond to equations (2a) and (2b) above. Each patient who completed a follow-up interview is included in this model; a patient who completed both the 9-and 18-month interview contributes two observations to the models. The first column of Table 2 shows coefficients and P values from a linear regression where the dependent variable was systolic blood pressure and explanatory variables included baseline characteristics of trial participants. The second column shows the same model with the addition of the fitted values from the chart-based systolic blood pressure model (this model is available from the author) as an explanatory variable. The addition of the fitted values adds significantly to the explanatory power of the model, as is demonstrated by the substantial increase in the adjusted R 2 , from 0.102 without the chart-based fitted values to 0.264 with them. The significant decrease in the coefficient on baseline blood pressure in model (2b) compared to (2a) likely reflects that the chart-based fitted values is picking up some of the variance explained by baseline trial-based blood pressure. A similar benefit of including fitted values from the chart-based model is shown for diastolic blood pressure in columns three and four.
Methods: Simulation to compare imputation methods that incorporate chart-based data with standard imputation methods Next, we ran simulations to explore whether using these chart-based fitted values in a single or multiple imputation algorithm improved the quality of the imputation of trial blood pressures. The strategy was to force two missing data mechanisms on the trial-based blood pressure data-a MAR mechanism and a missing not at random (MNAR) mechanism-and then compare how various imputation methods performed under these scenarios. To do this we first estimated a logit model where the dependent variable was a timevarying indicator for whether the patient's trial-based blood pres-sure data was missing at month 9 or 18, as shown in equation (3a). We then limited the dataset to only those patients with observed follow-up blood pressures. We calculated a scenario-modified predicted probability (P im ) of being missing at months m ϭ 9,18 for each patient as shown in equation (3b)
where f() is the logistic function, ␣ are the estimated coefficients from (3a) and Y s im are observed systolic trial-based blood pressures at month m for patient i transformed to a standard normal variable. By setting equal to different values we can affect an MAR or MNAR pattern of missing data on the observed data. Setting ϭ 0 effects an MAR missing data mechanisms while further from zero implies data that are MNAR. For example, ϭ log (1.5) has the effect of increasing the odds of being missing at follow-up 1.5-fold for every one standard deviation increase over the mean in observed study blood pressure at follow-up. Because the standard deviation of systolic blood pressure was 16.8 and the probability of missing was set at 25%, this implied that a patient whose observed blood pressure was 16.8 mm Hg higher than the mean at 9 months had a 33% probability (i.e., 1.5 times higher odds) of being assigned "missing" at 9 months. We conducted simulations with values for of 0, log (1.25), and log (1.5).
For each simulation, we drew a random variable from a Bernoulli(P im ) distribution, and replaced the observed systolic blood pressure for patient i at month m with a missing value if the Bernoulli random variable was equal to one. In each simulation 25% of the observed blood pressures were converted to missing values. This rate of missing was similar to that observed in our trial and other hypertension trials [15] , and is the attrition rate at which pathologies in imputation methodologies have been shown to occur [10] . In sensitivity analyses, we also used missing data rates of 10% and 40% (available from the author).
We then created six estimates of the missing blood pressures: two were derived from ad hoc imputation methods and four from regression-based methods. These are described in Table 3 . The two ad hoc methods were last data carry forward (LDCF) and next and last (NAL). NAL imputes the missing 9-month blood pressure with the average of the baseline and 18 month, provided the 18month data are available; otherwise it uses LDCF. We used two regression methods (XB) and (XB ϩ Cht) in which the predicted values of equations (2a) and (2b), respectively, were used to impute the missing blood pressure. The two equations differ in that the latter (XB ϩ Cht) includes the fitted value of the chart-based blood pressure as an additional covariate. In both cases, we added a Note: Fitted values are from mixed effects linear models of chart-based blood pressure as a function of time since randomization, evaluated at time ϭ 9 and 18 months. Models (2a) and (2b) are based on equations (2a) and (2b), respectively. AIC, Akaike information criterion; BMI, body mass index; BP, blood pressure. missing blood pressure value. We used the multiple imputation algorithm "ice" in Stata 10 (2007, Stata Corp, College Station, TX) to perform the imputations. The "ice" algorithm uses imputation by chained equations, which has been shown to work well when compared to the more classic imputation approach using imputations from Bayesian posterior distributions [16] . We compared the properties of the six models using bias ͩ bias ϭ 1 n ͚ ͑Ŷ im s Ϫ Y im s ͒ ͪ and the root mean squared deviation
where n is the number of individuals with "missing" and imputed blood pressures, Y s im is true systolic blood pressure for individual i at follow-up month m, and Ŷ s im is systolic blood pressure imputed by one of the six methods. We also calculated the proportion of variance (PV ϭ var(Ŷ s )/var(Y s ), where var(Ŷ s ) was calculated using Rubin's rule for the multiply imputed estimates, and coverage, which is the proportion of times the confidence interval for the mean of the imputed blood pressures included the mean of the true blood pressures. Each simulation involved 1000 replications and was conducted using Stata 10.
Results: Simulation to Compare Imputation Methods that Incorporate Chart-Based Data with Standard Imputation Methods Figure 1 shows the simulation results for imputing systolic blood pressure from 1000 replications where the missing data rate was set at 25%. Results for diastolic blood pressure (not shown) were similar to those for systolic; results for missing data rates of 10% and 40% were similar to those for 25% and are available from the author. The logistic model of missingness at follow-up that was used to estimate the coefficients in equation (3a) and effect the MAR and MNAR scenarios described below is also available from the author.
Results when the data are missing at random In the simulations that assumed a MAR missing data mechanism, the regression and multiple imputation methods generated imputations that were close on average to the true blood pressure measures, regardless of whether fitted values from charts were used to generate the imputation. However, incorporation of the chart-based fitted values led to lower RMSD for either the single imputation (RMSD for XB ϭ 29 vs. XB ϩ Cht ϭ 26) or the multiple imputation algorithm (RMSD for MI ϭ 30 vs. MI ϩ Cht ϭ 27). The estimates derived from multiple imputation were overdispersed (proportionate variance for MI ϭ 2.7; MI ϩ Cht ϭ 2.4), but the MI and MI ϩ Cht algorithms achieved coverages that were closest to nominal ( Table 4 ).
The two ad hoc imputation methods substantially overestimated the true blood pressure (LDCF bias ϭ 9.8 mm Hg; NAL bias ϭ 7.6 mm Hg), which should be expected given the downward trend over time in blood pressure in the trial. The proportionate variance shows that the ad hoc estimates were somewhat under-dispersed compared to true values (proportionate variance for LDCF ϭ 0.81; NAL ϭ 0.77). The substantial bias and underdispersion caused very poor coverage rates (Table 4) .
Results when the data are missing not at random. When the missing data are MNAR, the model-based estimates systematically imputed blood pressures that were biased downward as expected (Fig. 1) ; however, the versions of these methods that incorporate the chart-based fitted values were less biased (e.g., for ϭ log(1.5) bias XB ϭϪ8.2; XB ϩ Cht ϭ Ϫ6.6), had lower root mean squared deviations (e.g., for ϭ log(1.5) RMSD XB ϭ 31; XB ϩ Cht ϭ 28), and proportionate variances that were marginally closer to unity. The ad hoc methods were less biased under MNAR than under MAR but continued to impute blood pressure estimates that were too high, increasingly underdispersed, and had poor coverage properties. As discussed below, the bias was smaller for the ad hoc methods under MNAR not because these techniques were superior but because of the way the MNAR scenarios were designed.
Discussion
We described a new method for using longitudinal data abstracted from patients' charts to impute data missing from a clinical trial, and tested the method using data from a recently completed hypertension trial. We tested a two-step process in which we first estimated a longitudinal mixed model of the blood pressures abstracted from patients charts as a function of time and patientspecific random components to the intercept and time parameters, and recovered estimates of the patient-specific fitted values from this model on the day the patient was scheduled for a follow-up visit at 9 and 18 months after entry into the trial. This fitted value is an estimate, according to data recorded in the patient chart, of the patient's blood pressure on the day he or she was scheduled to return for a follow-up trial-based blood pressure reading. In the second step we used these fitted values to impute the missing trial-based blood pressures.
In simulations we found that this two-step process performed marginally better than regression-based single or multiple imputation methods that did not incorporate the chart-based fitted values. Incorporating fitted values from charts into a regressionbased single or multiple imputation algorithm yielded estimates with lower bias, lower mean squared deviation, and a proportionate variance closer to unity than did other estimates, even in simulations where a MNAR missing data mechanism was imposed. In these latter simulations, incorporating the fitted values from chart-based models ameliorated but did not eliminate the bias that is inherent when data are MNAR.
The interpretation of the simulation results is more complex for comparisons of ad hoc methods (such as LDCF) to the proposed new method, but the interpretation still suggests the marginal superiority of the new methods. For simulation scenarios in which the missing data are MAR, the novel method was clearly superior to the ad hoc approaches, but this may be more a function of the data we used than the methods. In the trial, blood pressures decreased over time so using the ad hoc method of imputing a missing follow-up blood pressure with a baseline value would naturally overestimate the follow-up blood pressure if the missing data are MAR. In the MNAR scenario, these ad hoc methods did not perform as badly, but this was mostly a function of how we designed the MNAR scenario. We assumed patients with high follow-up blood pressures were more likely to be "missing" at follow-up. Thus, the missing follow-up blood pressures were higher on average than the observed follow-up blood pressures. Because baseline blood pressures were also higher on average than observed follow-up blood pressures, using baseline blood pressures to impute missing blood pressures yields higher than average imputations, and consequently lower than average bias. However, this finding would be precisely reversed if we had said that lower follow-up blood pressures were more likely to be missing. Imputing lower-than-average follow-up blood pressures using higher-than-average baseline blood pressures in an ad hoc procedure would have exacerbated the missing data bias. Thus, choosing between an ad hoc method that has been recommended by some other studies [9] and the new methods developed here should best be made with a good understanding of the trends in the observed data over time and a reasonable conceptual model of why data are missing.
Our incorporation of chart-based data is similar to other data enhancement techniques [5, 17] in which data from administrative databases were used to replace or enhance clinical databases. In these studies, a potentially missing indicator for a risk factor for a given study subject was coded as present if either administrative or clinical data sources indicated that the risk factor was present during the calendar year. Our study differs from these analyses in that the timing of the measurement was critical; simply averaging chart-based blood pressure over a year would not capture the downward trend in blood pressure observed in the trial. Other studies that explored imputation of longitudinal missing data [3, 9] have found better results by using a patient's own data to impute missing observations rather than using the cross sectional mean of data from other patients. Our results are similar: using a patient's own data abstracted from clinical charts proved useful for predicting a patient's missing trial-based data.
The mechanism by which the chart-based method improved regression-based single or multiple imputation is fairly straightforward. The chart-based multilevel model included patient specific intercepts and patient-specific time trends, so that a prediction of chart-based blood pressure for a particular patient on a particular day could be derived regardless of whether or not a patient had an outpatient visit on that day. These predicted chartbased blood pressures were highly correlated with observed trialbased blood pressures taken on that day. This is evidenced by a regression of trial-based blood pressures on chart-based fitted values (equation (2b)) in which the coefficient on the chart-based values was 0.845 and highly significant (P Ͻ 0.001). This suggests that for a patient who had a chart-based fitted value of blood pressure 10 mm Hg higher than average at follow-up, we would expect an 8.45 mm Hg higher than average blood pressure if the patient kept the follow-up appointment with trial personnel on that day. The inclusion of chart-based fitted values in the regression resulted in a greater than 2.5-fold increase in the regression's adjusted R 2 . Because of this high correlation, the inclusion of these fitted values led to better estimates of the missing trial-based blood pressures.
In addition, because the chart-based fitted values are estimates of what the missing blood pressure would have been had it been measured in the trial, their inclusion in an imputation algorithm helped to reduce the missing data bias in MNAR situations where the probability of being missing was a function of the missing blood pressure value. Other studies have found that when data are MNAR traditional multiple imputation techniques cannot over- come this inherent missing data bias [10] . The methods we described here also did not, but they moved the point estimate in the direction of less bias. Researchers might be compelled to use simpler techniques to incorporate data from charts, but these would not have been feasible for our trial. For example, if a patient made a clinic visit on or near the date of a scheduled follow-up trial visit, one might consider simply using the chart-based blood pressure data from that visit in place of the missing trial observation, but this simple solution is complicated by two facts. In our trial relatively few patients (16 of 152) had outpatient visits within the protocol-specified window of the scheduled-but-missed trial follow-up visits. In addition, the trial-based blood pressures were systematically higher than the chart-based blood pressures, which implies that simply substituting a chart-based blood pressure for a missing trial observation would lead to biased estimates of the trial-based blood pressure. The methods we describe overcome both of these obstacles. By predicting chart-based blood pressure on the day of the missed trial-based measurement we overcame the problem of timing, and by using the predicted chart-based blood pressure as a regressor in an imputation equation, rather than as the imputation itself, we overcame the problem of the differences in levels between trial-and chart-based blood pressures.
Recommendations
Although we demonstrate the methods using blood pressure data, these methods might be useful in many situations where important variables are collected for a trial, and also collected as a part of routine medical care. Examples include vital statistics and lab values for patients with chronic diseases, which are routinely collected and will become more easily assessable by trial personnel as more outpatient clinics adopt electronic health records. If a researcher wants to explore the use of these data for imputing trial data we recommend three steps. First, estimate an equation similar to equation (1) on the chart data, incorporating the powers of time and patient-level random effects that make sense. Second, estimate an equation similar to (2b) to see if the fitted values from (1) are significant predictors of observed follow-up trial-based measures. If they are, then using these fitted values in a regression-based imputation algorithm is prudent. Third, estimate an equation similar to (3c) below, in which the probability of being missing at follow-up is modeled as a function of the fitted values from (1).
Pr(Missing im ϭ 1) ϭ logistic (a 0 ϩ a 1 x 1 ϩ a 2 Y i0 s ϩ a 3 I 18 (m) ϩ a 4 Ŷ im c )
If the fitted values were significant predictors of observed trial data in (2b), then the coefficient on fitted values in (3c) provide a test of the MAR assumption. A statistically significant coefficient on the fitted values suggests that the missing data might be MNAR, and the sign of the coefficient indicates the direction of the missing data bias. In our data, this was a particularly weak test. In 1000 simulations with an MNAR of ϭ log(1.5), this coefficient was significant and negative in only 25 simulations, which is what one would expect by chance.
Limitations
Some important limitations should be noted. We imposed an MNAR missing data mechanism on data that were in fact not missing. It is not clear if the chart-based fitted values would be as highly correlated with the blood pressures of patients who did not return for a follow-up visit. We preformed this analysis using linear models on blood pressure data that are normally distributed. It is not clear if applying these methods using nonlinear models and non-normally distributed data would yield similar results. These methods would not be useful if missing follow-up data were caused by active withdrawal from a trial and a concomi-tant withdrawal of permission to use data abstracted from a patient's chart. Finally, we used only one multiple imputation routine (the "ice" algorithm in Stata 10), although several alternative algorithms exist.
Conclusions
Chart-based blood pressure measurements can be effectively used to impute missing blood pressure data in a clinical trial. A two-step process of estimating a longitudinal mixed model on the chart data, and using the fitted values from this model as explanatory variables in a regression-based imputation algorithm led to imputed blood pressure values with lower bias and smaller root mean squared deviations than did imputation algorithms that did not incorporate the chart-based blood pressures. This technique might be useful for imputing a variety of longitudinal data that are missing from a clinical trial but collected during routine clinical visits outside the trial.
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